Log In
Print
BCIQ
Print
Print this Print this
 

paroxetine (Brisdelle) (formerly Mesafem)

Also known as: low-dose paroxetine mesylate (low-dose mesylate salt of paroxetine (LDMP))

  Manage Alerts
Collapse Summary General Information
Company Hisamitsu Pharmaceutical Co. Inc.
DescriptionLow-dose paroxetine mesylate, a selective serotonin reuptake inhibitor (SSRI)
Molecular Target
Mechanism of ActionSelective serotonin reuptake inhibitor (SSRI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat vasomotor symptoms associated with menopause
Regulatory Designation U.S. - Special Protocol Assessment (Treat vasomotor symptoms associated with menopause);
U.S. - Undisclosed Review (Treat vasomotor symptoms associated with menopause)
Partner Shionogi & Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$428.0M

$428.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today